Note: Ingredients listed on restricted chemical lists
EC/CAS
200-664-3/67-68-5
Name of the chemical
dimethyl sulphoxide
Concentration
<9%
EC/CAS
55965-84-9
Name of the chemical
Mixture of 5-chloro-2-methyl-2H- isothiazol-3-one (EINECS 247-500-7) and 2-methyl-2H-isothiazol-3-one (EINECS 220-239-6)
Concentration
006%
General Information
Revision date
2015-08-20
Product name
MAS UA Controls
Product Synonyms
UAB-115 MAS® UA Liquid Urinalysis Control, Level 1 UAB-160 MAS® UA Liquid Urinalysis Control, Level 1 UAB-215 MAS® UA Liquid Urinalysis Control, Level 2 UAB-260 MAS® UA Liquid Urinalysis Control, Level 2 UAB-MP MAS® UA Liquid Urinalysis Control Multi-Pack UAT-MP MAS® UA DipTube Liquid Urinalysis Control Multi-Pack UAT-S MAS® UA DipTube Liquid Urinalysis Control Sample Pack UAT-BP MAS® UA DipTube Liquid Urinalysis Control Bulk Pack
Chemical name
Mixture
1.2.1 Relevant identified uses
In vitro diagnostic kit and uses advised against
Emergency telephone
+1 (800) 424-9300, +1 (703) 527-3887, +1 (202) 483-7616
Icons in SDS
Company Information
company name
Microgenics Corporation
e-mail address of the competent person responsible for the Safety Data Sheet
techservice.mgc@thermofisher.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H317, H334
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
substance or mixture Globally Harmonized Skin Sensitizer - Category 1. Respiratory Sensitizer - Category 1. System [GHS] Other/Supplemental Mixture not yet fully tested.
2.2 Label elements
SECTION 2 - HAZARDS IDENTIFICATION …continued
Signal word
Danger
Hazard statements
H317 - May cause allergic skin reaction. H334 - May cause allergy or asthma symptoms or breathing difficulties if inhaled. not be allowed out of the workplace. P280 - Wear protective gloves/eye protection/ face protection. P285 - In case of inadequate ventilation wear respiratory protection. P302 + P352 - If on skin: Wash with plenty of soap and water. P304 + P341 - IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. P333 + P313 - If skin irritation or rash occurs: Get medical advice/attention. P342 + P311 - If experiencing respiratory symptoms: Call a POISON CENTER or doctor/physician. P363 - Wash contaminated clothing before reuse. P501 - Dispose of contents/container to location in accordance with local/regional/national/international regulations.
Precautionary statements
P261 - Avoid breathing mist or vapor. P272 - Contaminated work clothing should
2.3 Other hazards
The potential health hazards associated with exposure/handling of this mixture are unknown; no data specific for the mixture were identified. The following data describe the hazards of individual ingredients, where applicable. This product contains human urine and should be treated/handled as a potential biohazard. All such human urine has been derived from donors tested individually and shown by FDA approved methods to be free from antibodies to Human Immune Deficiency Virus and Hepatitis B and C. As no test method can offer complete assurance that these or other infectious agents are not present, this product should be handled using standard biosafety precautions. Because the mixture contains a protein (bovine serum albumin) it may cause an allergic skin or respiratory reaction (e.g., potential to cause anaphylaxis). In a workplace setting, the likelihood of systemic effects following accidental ingestion is low, due to the rapid breakdown of proteins in the digestive tract. Bovine serum albumin has been associated with occupational sensitization. Material produced in compliance with USDA and/or CPMP/BWP/1230/98 (Guidance on Minimizing the Risk of Transmitting Animal Spongiform Encephalopathy Agents via Medicinal Products). This is a CPMP/BWP/1230/98 Category IV material: it does not contain nor is it derived from specified risk materials as defined in Commission decision 97/534/EC (or successive amendments). Note